BioAdvance News Portfolio News Senzo

Senzo lands $2M investment to advance at-home tests for infectious diseases

By WebmasterJuly 21, 2022November 1st, 2024No Comments

Senzo lands $2M investment to advance at-home tests for infectious diseases

Previous PostNew Zealand Endovascular Thought Leader Joins the VESTECK Scientific Advisory Board
Next PostRelmada Therapeutics Appoints Biopharmaceutical Marketing and Commercial Planning Veteran John Hixon as Head of Commercial